This inventor holds 5 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Beone Medicines I Gmbh, Beigene, Ltd., Beone Medicines | Gmbh. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 14 
1 out of 54 
1 out of 5 Years Active: 2025-2026
Title: Jianzhuang Miao: Innovator in Cancer Treatment
Introduction
Jianzhuang Miao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in cancer treatment.
Latest Patents
Jianzhuang Miao holds a patent for "Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist." This patent discloses an imidazo [2, 1-f] [1, 2, 4] triazin-4-amine derivative, or a stereoisomer thereof, which is useful as a TLR7 agonist. The patent also includes a pharmaceutical composition comprising this compound and outlines a method for treating cancer using the derivative or its stereoisomers.
Career Highlights
Jianzhuang Miao is currently associated with Beigene, Ltd., a leading biotechnology company focused on molecularly targeted and immuno-oncology drug discovery. His work at Beigene has positioned him as a key player in the development of innovative cancer therapies.
Collaborations
He collaborates with notable colleagues, including Guoliang Zhang and Changyou Zhou, who contribute to his research and development efforts in the pharmaceutical field.
Conclusion
Jianzhuang Miao's innovative work in cancer treatment through his patented compounds showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his collaborations further enhance the impact of his research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile